News Quantified

PLSE – pulse biosciences, inc (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting [Yahoo! Finance]

Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? [Yahoo! Finance]

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

-14.6%

BEAT

-3.5%

BEAT

11.2%

MISS

Oppenheimer Holdings, Inc.

Form 8-K PULSE BIOSCIENCES, INC. For: Mar 03

Form 8-K/A PULSE BIOSCIENCES, INC. For: Feb 27

Form EFFECT PULSE BIOSCIENCES, INC.

Form 8-K PULSE BIOSCIENCES, INC. For: Feb 27

Form 4 PULSE BIOSCIENCES, INC. For: Feb 18 Filed by: Danahy Kevin Patrick

Top News Gainers

3/16 Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results 33.7%

4/6 Form S-3 Pulse Biosciences, Inc. 11.5%

4/29 Pulse Biosciences Schedules First Quarter 2020 Financial Results Conference Call for May 11, 2020 7.8%

9/10 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.5%

3/31 Form 10-K/A Pulse Biosciences, Inc. For: Dec 31 6.7%

4/14 Form S-3/A Pulse Biosciences, Inc. 5.9%

2/11 Pulse Biosciences Inc (NASDAQ: PLSE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%

4/21 Form S-3/A Pulse Biosciences, Inc. 5.0%

12/19 Form 8-K Pulse Biosciences, Inc. For: Dec 19 4.8%

9/4 Pulse Biosciences Grants Equity Incentive Awards to New Employees 4.2%

Top News Decliners

2/13 Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in Dermatology -29.8%

5/1 Form S-3/A Pulse Biosciences, Inc. -23.4%

3/17 Pulse Biosciences Grants Equity Incentive Awards to New Employees -10.3%

4/14 Form DEF 14A Pulse Biosciences, Inc. For: Apr 14 -7.8%

8/8 Form 10-Q Pulse Biosciences, Inc. For: Jun 30 -6.9%

12/18 Pulse Biosciences Updates on Regulatory Progress -5.4%

11/19 Form 3 Pulse Biosciences, Inc. For: Nov 18 Filed by: GARDINER SANDRA A. -4.9%

3/12 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -4.4%

5/17 Form 8-K Pulse Biosciences, Inc. For: May 16 -4.4%

9/26 Pulse Biosciences Inc (NASDAQ: PLSE) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day